Page last updated: 2024-08-24

irinotecan and furamidine

irinotecan has been researched along with furamidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frese, S; Frese-Schaper, M; Keil, A; Körner, M; Schmid, RA; Steiner, SK	1

Other Studies

1 other study(ies) available for irinotecan and furamidine

Article	Year
The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis. Arthritis & rheumatology (Hoboken, N.J.), 2015, Volume: 67, Issue:7 Topics: Animals; Benzamidines; Camptothecin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Immunomodulation; Irinotecan; Lupus Nephritis; Mice; Mice, Inbred NZB; Phosphoric Diester Hydrolases; Topoisomerase I Inhibitors; Treatment Outcome	2015

Article

Year

The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis.

Arthritis & rheumatology (Hoboken, N.J.), 2015, Volume: 67, Issue:7

Topics: Animals; Benzamidines; Camptothecin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Immunomodulation; Irinotecan; Lupus Nephritis; Mice; Mice, Inbred NZB; Phosphoric Diester Hydrolases; Topoisomerase I Inhibitors; Treatment Outcome

2015